NEW FILINGS
Company: AFC Gamma, Inc.
Symbol: AFCG
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: AFC Gamma, Inc. is a commercial real estate finance company founded in July 2020 by a veteran team of investment professionals.
Underwriter(s): JMP Securities, Ladenburg Thalmann, Seaport Global
Co-Manager: Lake Street
Filed: 1-22-21
Listed Cash Raise: $115m
Company: Caliber Home Loans, Inc.
Symbol: HOMS
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a proven leader in the U.S. mortgage market with a uniquely diversified, customer-centric, purchase-focused platform.
Underwriter(s): Credit Suisse, Goldman Sachs, Barclays, BofA Securities, Citigroup, UBS Investment Bank, Wells Fargo Securities
Co-Manager: Deutsche Bank Securities, Keefe, Bruyette & Woods, Drexel Hamilton, Loop Capital Markets, R. Seelaus & Co., LLC, Tigress Financial Partners
Filed: 1-21-21
Listed Cash Raise: $100m
Postponed in October 2020
Company: Bioventus Inc..
Symbol: BVS
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a global medical device company focused on developing and commercializing clinically differentiated, cost efficient and minimally invasive treatments that engage and enhance the body’s natural healing process.
Underwriter(s): Morgan Stanley, JP Morgan, Goldman Sachs
Co-Manager: Canaccord Genuity
Filed: 1-20-21
Listed Cash Raise: $100m
Company: Signify Health, Inc..
Symbol: SGFY
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: Signify Health is a leading healthcare platform that leverages advanced analytics, technology, and nationwide healthcare provider networks to create and power value-based payment programs.
Underwriter(s): Goldman Sachs, JP Morgan, Barclays, Deutsche Bank Securities, BofA Securities, UBS Investment Bank, Baird, Piper Sandler, William Blair
Filed: 1-19-21
Listed Cash Raise: $100m
Company: NexImmune, Inc.
Symbol: NEXI
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response that mimics natural biology.
Underwriter(s): Barclays, Cantor, Raymond James, Allen & Co.
Filed: 1-19-21
Listed Cash Raise: $86.25m
Company: Adagene Inc.
Symbol: ADAG
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies.
Underwriter(s): Goldman Sachs, Morgan Stanley, Jefferies
Co-Manager: China Renaissance
Filed: 1-19-21
Listed Cash Raise: $100m
Company: Cloopen Group Holding Limited
Symbol: RAAS
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are the largest multi-capability cloud-based communications solution provider in China, as measured by revenues in 2019, according to the CIC report(1)
Underwriter(s): Goldman Sachs, Citigroup, CICC
Filed: 1-19-21
Listed Cash Raise: $100m
Company: Telus International (Cda), Inc.
Symbol: TINT
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a leading digital customer experience innovator that designs, builds and delivers next-generation solutions for global and disruptive brands.
Underwriter(s): JP Morgan, Morgan Stanley, Barclays, BofA Securities, CIBC Capital, Citigroup, Credit Suisse, RBC Capital, Baird, BMO Capital
Co-Manager(s): Scotiabank, TD, Wells Fargo, William Blair, MUFG, National Bank of Canada Financial Markets
Filed: 1-19-21
Listed Cash Raise: $100m
Company: Decipher Biosciences, Inc.
Symbol: DECI
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a commercial-stage precision oncology company committed to improving patient care, with a focus in urologic oncology specific to prostate and bladder cancers.
Underwriter(s): Evercore ISI, Wells Fargo
Co-Manager(s): Canaccord Genuity, BTIG
Filed: 1-19-21
Listed Cash Raise: $100m
Company: Bolt Therapeutics, Inc.
Symbol: BOLT
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems.
Underwriter(s): Morgan Stanley, SVB Leerink, Stifel, Guggenheim Securities
Filed: 1-15-21
Listed Cash Raise: $100m
Company: Vor Biopharma, Inc.
Symbol: VOR
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: The mission of Vor Biopharma is to develop transformative treatments for patients suffering from hematological malignancies.
Underwriter(s): Goldman Sachs, Evercore ISI, Barclays, Stifel
Filed: 1-15-21
Listed Cash Raise: $150m
Company: Terns Pharmaceuticals, Inc.
Symbol: TERN
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases.
Underwriter(s): JP Morgan, Goldman Sachs, Cowen
Filed: 1-15-21
Listed Cash Raise: $100m
Company: Angion Biomedica Corp.
Symbol: ANGN
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a late-stage biopharmaceutical company focused on the discovery, development and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases.
Underwriter(s): Cowen, Stifel
Filed: 1-15-21
Listed Cash Raise: $75m
Postponed in October 2015
Company: PurposeBuilt Brands, Inc.
Symbol: PBLT
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: PurposeBuilt Brands is a high-growth portfolio of category-leading, efficacy-driven specialty cleaning and disinfection brands with a 40-year track record of successive annual sales growth.
Underwriter(s): Barclays, Morgan Stanley, Goldman Sachs, Baird, BofA Securities, Credit Suisse, UBS Investment Bank
Co-Manager: Academy Securities, Blaylock Van LLC, R. Seelaus & Co., Ramirez & Co., TCG Capital
Filed: 1-15-21
Listed Cash Raise: $100m
Company: Lucira Health, Inc.
Symbol: LHDX
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a medical technology company focused on the development and commercialization of transformative and innovative infectious disease test kits.
Underwriter(s): BofA Securities, William Blair
Co-Manager: LifeSci Capital
Filed: 1-15-21
Listed Cash Raise: $115m
Company: Apria, Inc.
Symbol: APR
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a leading provider of integrated home healthcare equipment and related services in the United States.
Underwriter(s): Citigroup, Goldman Sachs, BofA Securities, JP Morgan
Co-Manager: Piper Sandler, Fifth Third Securities, TD Securities
Filed: 1-15-21
Listed Cash Raise: $100m
Company: LumiraDx Limited
Symbol: LMDX
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a next-generation point of care, or POC, diagnostic company addressing the current limitations of legacy POC systems by bringing lab-comparable performance to the POC in minutes, on a single instrument with a low cost of ownership.
Underwriter(s): Jefferies, SVB Leerink, Evercore ISI, Raymond James
Filed: 1-15-21
Listed Cash Raise: $100m
Company: Immunocore Holdings plc
Symbol: IMCR
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune.
Underwriter(s): Goldman Sachs, JP Morgan, Jefferies
Filed: 1-15-21
Listed Cash Raise: $100m
Company: Pharvaris B.V.
Symbol: PHVS
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.
Underwriter(s): Morgan Stanley, BofA Securities, SVB Leerink
Co-Manager: Oppenheimer, Kempen & Co.
Filed: 1-15-21
Listed Cash Raise: $100m
Company: Sensei Biotherapeutics, Inc.
Symbol: SNSE
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: They are an immunotherapy company engaged in the discovery and development of next-generation therapies with an initial focus on treatments for cancer
Underwriter(s): Citigroup, Piper Sandler, Berenberg
Co-Manager: Oppenheimer
Filed: 1-15-21
Listed Cash Raise: $100m
Company: Bumble, Inc.
Symbol: BMBL
Shares: TBD
Price Range: TBD
Trade Date: TBD
Description: The Bumble brand was built with women at the center—where women make the first move.
Underwriter(s): Goldman Sachs, Citigroup, Morgan Stanley, JP Morgan
Filed: 1-15-21
Listed Cash Raise: $100m
Terms Added
Company: Shoals Technology Group, Inc.
Symbol: SHLS
Description: They are a leading provider of electrical balance of system or “EBOS” solutions for solar energy projects in the United States.
Shares: 50 million
Price Range: $19.00-$21.00
Market Cap: TBD
Trade Date: Wednesday, 1/27
Underwriter(s): Goldman Sachs, J.P. Morgan, Guggenheim Securities, UBS Investment Group, Morgan Stanley, Barclays, Credit Suisse
Co-Manager(s): Cowen, Oppenheimer
Terms Added: 1-19-21
Company: Qualtrics International Inc.
Symbol: XM
Description: They have pioneered a new category of software, experience management, or XM, which enables organizations to succeed in today’s experience economy.
Shares: 49.2 million
Price Range: $22.00-$26.00
Market Cap: $11.1b-$13.1b
Trade Date: Thursday, 1/28
Underwriter(s): Morgan Stanley, J.P. Morgan, BofA Securities, Barclays, Deutsche Bank Securities, Goldman Sachs, HSBC, Citigroup, BMO Capital Markets, Truist Securities, Canaccord Genuity, Evercore ISI, JMP Securities, Oppenheimer & Co., Piper Sandler, Raymond James, William Blair
Co-Managers: Loop Capital Markets, Ramirez & Co., R. Seelaus & Co. LLC.
Terms Added: 1-19-21
Company: Ortho Clinical Diagnostics Holdings plc
Symbol: OCDX
Shares: 70 million
Price Range: $20.00-$23.00
Market: Cap: 4.35b-$5.0b
Trade Date: Thursday, 1/28
Description: They are a pure-play in vitro diagnostics (“IVD”) business driven by our credo, “Because Every Test is A Life.”
Underwriter(s): J.P. Morgan, BofA Securities, Goldman Sachs, Barclays, Morgan Stanley, Citigroup, Credit Suisse, UBS Investment Bank, Evercore ISI, Piper Sandler
Co-Manager(s): ING, Macquarie Capital, , Nomura, TCG Capital Markets, Drexel Hamilton, H.C. Wainwright, Ramirez & Co., Siebert Williams Shank
Terms Added: 1-19-21
Company: Vinci Partners Investments Ltd.
Symbol: VINP
Shares: 13.8 million
Price Range: $16.00-$18.00
Market Cap: $888m-$1.0bn
Trade Date: Thursday, 1/28
Description: Vinci Partners is a leading alternative investment platform in Brazil, established in 2009.
Underwriters: JP Morgan, Goldman Sachs, BTG Pactual, Itau BBA, BofA Securities, Credit Suisse, UBS Investment Bank
Terms Added: 1-19-21
Company: ZIM Integrated Shipping Services Ltd.
Symbol: ZIM
Description: They are a global, asset-light container liner shipping company with leadership positions in niche markets where we believe we have distinct competitive advantages that allow us to maximize our market position and profitability.
Shares: 17.5 million
Price Range: $16.00-$19.00
Market Cap: $1.6b-$1.9b
Trade Date: Thursday, 1/28
Terms Added: 1-19-21
Company: Southeastern Grocers, Inc.
Symbol: SEGR
Description: They are a leading regional food retailer based on revenue and number of stores we operate with a long-standing history in the Southeastern United States, serving highly attractive markets throughout Florida, Georgia, Alabama, Louisiana and Mississippi.
Shares: 8.9 million
Price Range: $14.00-$16.00
Market Cap: $607m-$694m
Trade Date: Friday, 1/29
Underwriter(s): BofA Securities, Goldman Sachs
Co-Manager(s): Deutsche Bank Securities, BMO Capital Markets, Truist Securities, Wells Fargo Securities
Terms Added: 1-21-21